Financial Statements Release 2008

February 24, 2009 12:14 ET | Source: Genmab A/S Genmab A/S

In order to read Genmab's Financial Statements Release 2008, please see the
attached file.

Attachments

052009_financialstatement2008_240209_uk.pdf

052009_financialstatement2008_240209_uk.pdf...

Recommended Reading

June 29, 2026 16:14 ET | Source: Genmab A/S

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Company Announcement Topline results from Phase 3 EPCORE® DLBCL-4 evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful...
Read More

$Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival$
June 16, 2026 15:12 ET | Source: Genmab A/S

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; June 16, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 185 shares as a consequence of the exercise of employee warrants. The increase...
Read More